Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

87
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
87
Cancer Survival Analysis01:21

Cancer Survival Analysis

355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MALDI-TOF MS Classification of Formosan Thraustochytrids and Their Use in Shrimp Farming.

Journal of agricultural and food chemistry·2026
Same author

Photo-assisted synthesis of ternary metal (oxy)hydroxide electrode for enhanced seawater splitting and solar-to-hydrogen conversion.

Journal of colloid and interface science·2025
Same author

Aspirin Is as Effective as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

The Journal of arthroplasty·2025
Same author

SCO6564, a novel 3-ketoacyl acyl carrier protein synthase III, contributes in fatty acid synthesis in Streptomyces coelicolor.

PloS one·2025
Same author

Enhanced d-pantothenic acid biosynthesis by plasmid-free Escherichia coli through sodium pyruvate addition combined with glucose and temperature control strategy.

Journal of applied microbiology·2024
Same author

Macrophage-mediated mechanisms of lung injury in the sensitization reaction to <i>Echinococcus granulosus</i>.

Frontiers in immunology·2024

Related Experiment Video

Updated: Jul 6, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Developing a Prognostic Model for Primary Biliary Cholangitis Based on a Random Survival Forest Model.

Xin-Yu Fu1, Ya-Qi Song2, Jia-Ying Lin1

  • 1Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.

International Journal of Medical Sciences
|January 2, 2024
PubMed
Summary
This summary is machine-generated.

A new machine learning model accurately identifies high-risk patients with primary biliary cholangitis (PBC)-associated cirrhosis. This prognostic tool enables targeted treatments, potentially improving outcomes for those with this rare autoimmune liver disease.

Keywords:
Primary Biliary CholangitisPrognosisRandom Survival ForestRisk assessment

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

290
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Related Experiment Videos

Last Updated: Jul 6, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

290
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Area of Science:

  • Hepatology and autoimmune liver diseases.
  • Machine learning applications in clinical prognostication.
  • Biostatistics and survival analysis.

Background:

  • Primary biliary cholangitis (PBC) is a progressive autoimmune liver disease with limited treatment options and rising incidence.
  • Accurate identification of high-risk patients is crucial for developing targeted therapeutic strategies.
  • Existing prognostic models may not fully capture the complexity of PBC progression.

Purpose of the Study:

  • To develop and validate a machine learning-based prognostic model for patients with PBC-associated cirrhosis.
  • To identify key clinical variables predictive of prognosis in PBC.
  • To stratify patients into distinct risk groups for personalized treatment.

Main Methods:

  • Retrospective analysis of clinical and follow-up data from 90 PBC-associated cirrhosis patients (2011-2021).
  • Construction of a prognostic model using the random survival forest algorithm in R.
  • Cox univariate regression analysis to select initial predictive variables.
  • Model validation using out-of-bag error and C-index.

Main Results:

  • A final predictive model was developed using cholinesterase, bile acid, white blood cell count, total bilirubin, and albumin.
  • The model achieved an out-of-bag error of 0.2002 and a C-index of 0.7805.
  • The model effectively stratified patients into high- and low-risk groups (P < 0.0001) with high predictive accuracy at 1, 3, and 5 years (AUCs: 0.9595, 0.8898, 0.9088).

Conclusions:

  • A random survival forest model provides an accurate prognostic tool for PBC-associated cirrhosis.
  • The model enables effective risk stratification, facilitating targeted treatment strategies.
  • Improved patient outcomes are anticipated through personalized management of high-risk individuals.